Real‐World Comparisons of Low‐Dose NOACs versus Standard‐Dose NOACs or Warfarin on Efficacy and Safety in Patients with AF: A Meta‐Analysis

Z Li, X Wang, D Li, A Wen - Cardiology Research and Practice, 2022 - Wiley Online Library
Objective. We aimed to further investigate the efficacy and safety of low‐dose NOACs by
performing a meta‐analysis of cohort studies. Background. Meta‐analyses of randomized …

Real-World Comparisons of Low-Dose NOACs versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Patients with AF: A Meta-Analysis

Z Li, X Wang, D Li, A Wen - Cardiology research and …, 2022 - pubmed.ncbi.nlm.nih.gov
Objective We aimed to further investigate the efficacy and safety of low-dose NOACs by
performing a meta-analysis of cohort studies. Background Meta-analyses of randomized …

Real-World Comparisons of Low-Dose NOACs versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Patients with AF: A Meta-Analysis

Z Li, X Wang, D Li, A Wen - Cardiology Research and Practice, 2022 - search.proquest.com
Objective. We aimed to further investigate the efficacy and safety of low-dose NOACs by
performing a meta-analysis of cohort studies. Background. Meta-analyses of randomized …

[HTML][HTML] Real-World Comparisons of Low-Dose NOACs versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Patients with AF: A Meta-Analysis

Z Li, X Wang, D Li, A Wen - Cardiology Research and Practice, 2022 - ncbi.nlm.nih.gov
Objective We aimed to further investigate the efficacy and safety of low-dose NOACs by
performing a meta-analysis of cohort studies. Background Meta-analyses of randomized …

Real-World Comparisons of Low-Dose NOACs versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Patients with AF: A Meta-Analysis.

Z Li, X Wang, D Li, A Wen - Cardiology Research and Practice, 2022 - europepmc.org
Objective We aimed to further investigate the efficacy and safety of low-dose NOACs by
performing a meta-analysis of cohort studies. Background Meta-analyses of randomized …

Real-World Comparisons of Low-Dose NOACs versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Patients with AF: A Meta-Analysis.

Z Li, X Wang, D Li, A Wen - Cardiology Research & Practice, 2022 - search.ebscohost.com
Objective. We aimed to further investigate the efficacy and safety of low-dose NOACs by
performing a meta-analysis of cohort studies. Background. Meta-analyses of randomized …

[PDF][PDF] Real-World Comparisons of Low-Dose NOACs versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Patients with AF: A Meta-Analysis

Z Li, X Wang, D Li, A Wen - Studies in Epidemiology) guidelines, 2022 - scienceopen.com
Objective. We aimed to further investigate the efficacy and safety of low-dose NOACs by
performing a meta-analysis of cohort studies. Background. Meta-analyses of randomized …

Real-World Comparisons of Low-Dose NOACs versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Patients with AF: A Meta-Analysis.

Z Li, X Wang, D Li, A Wen - Cardiology Research & Practice, 2022 - search.ebscohost.com
Objective. We aimed to further investigate the efficacy and safety of low-dose NOACs by
performing a meta-analysis of cohort studies. Background. Meta-analyses of randomized …

[引用][C] Real-World Comparisons of Low-Dose NOACs versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Patients with AF: A Meta-Analysis

Z Li, X Wang, D Li, A Wen - Studies in Epidemiology) guidelines, 2022